Cronos Group Inc vs MaxLinear Inc. Common Stock — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while MaxLinear Inc. Common Stock trades at $96.37 (market cap $8.50B). The key difference: MaxLinear Inc. Common Stock is far larger — about 7.2× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (968,037 versus 4,008,439). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and MaxLinear Inc. Common Stock for 0 Days on average.
| CRON | MXL | |
|---|---|---|
Market Cap | $1.18B | $8.50B |
Volume | 968,037 | 4,008,439 |
Sector | Health | Technology |
52-Week High | $3.55 | $128.03 |
52-Week Low | $2.30 | $13.05 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $387.62M | $8.58B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →